Synlett 2007(1): 0059-0062  
DOI: 10.1055/s-2006-958421
LETTER
© Georg Thieme Verlag Stuttgart · New York

Aluminum Iodide Promoted Highly Z-Stereoselective Synthesis of β-Iodo Morita-Baylis-Hillman Esters with Ketones as Aldol Acceptors

Sung Il Leea, Geum-Sook Hwang*b, Do Hyun Ryu*a
a Department of Chemistry, Sungkyunkwan University, Suwon 440-746, Korea
Fax: +82(31)2905976; e-Mail: dhryu@skku.edu;
b Korea Basic Science Institute, 5 St, Anam-Dong, Seongbuk-Gu, Seoul 136-701, Korea
Fax: +82(2)9200779; e-Mail: gshwang@kbsi.re.kr;
Further Information

Publication History

Received 11 October 2006
Publication Date:
20 December 2006 (online)

Abstract

Aluminum iodide has been found to promote the ­efficient and highly stereoselective synthesis of (Z)-β-iodo-α-­(hydroxyalkyl)acrylates via one-pot three-component coupling ­reactions. This new system has made it possible to utilize various ketones as the electrophiles, in order to react with an aluminum ­allenoate intermediate for the synthesis of β-iodo Morita-Baylis-Hillman adducts with high yield and excellent Z-stereoselectivity (>99%).

10

AlI3 appeared superior to other metal iodides, such as MgI2 (79% yield, Z/E = 91:9) or TiI4 (<10% yield) in terms of Z/E selectivity and chemical yield when using benzaldehyde as the electrophilic acceptor.

12

The formation of allenoate was expected from the isolation of β-iodo ethyl acrylate after aqueous work-up without adding electrophilic acceptors.

13

Experimental Procedure: CH2Cl2 (2.0 mL) was slowly added to an aluminum iodide (0.22 mmol) at -78 °C under N2. Ethyl propiolate (0.24 mmol) and the ketone (0.20 mmol) were added sequentially. The reaction was monitored by TLC. After the reaction time indicated in Table [1] , it was quenched with H2O (2.0 mL) and an aqueous layer was extracted with CH2Cl2. The combined organic phase was dried over Na2SO4 and the solvent was removed under vacuum. The crude product was purified by column chromatography (CH2Cl2-hexane 3:1) to provide a pure product.
( Z )-Ethyl 3-[4-(Trifluoromethyl)phenyl]-3-hydroxy-2-(iodomethylene)butanoate (Entry 13).
IR: 3476, 2983, 1718, 1327, 1124, 845 cm-1. 1H NMR (500 MHz, CDCl3): δ = 7.60 (2 H, d, J = 8.0 Hz), 7.54 (2 H, d, J = 8.5 Hz), 7.24 (1 H, s), 4.17 (2 H, m), 4.08 (1 H, br s), 1.70 (3 H, s), 1.16 (3 H, t, J = 7.5 Hz). 13C NMR (125 MHz, CDCl3): δ = 167.74, 149.20, 148.92, 129.95 (q, J = 129.5 Hz), 125.71, 125.53, 124.26 (q, J = 540.8 Hz), 84.81, 77.89, 62.05, 28.94, 13.98. MS: m/e (relative intensity) = 414 (0.2) [M+], 399 (48), 354 (12), 271 (100), 244 (24), 175 (6).
( Z )-Ethyl 3-Hydroxy-2-(iodomethylene)-3-(4-methoxy-phenyl)butanoate (Entry 14).
IR: 3464, 2920, 1719, 1509, 1027, 505 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.22 (2 H, d, J = 8.7 Hz), 7.03 (1 H, s), 6.86 (2 H, d, J = 8.7 Hz), 4.12 (2 H, q, J = 6.9 Hz), 3.66 (1 H, s), 1.70 (3 H, s), 1.53 (3 H, s) 1.19 (3 H, t, J = 7.2 Hz). 13C NMR (125 MHz, CDCl3): δ = 168.04, 159.13, 150.59, 136.97, 130.58, 113.82, 83.26, 77.80, 61.78, 55.47, 28.94, 14.09. MS: m/e (relative intensity) = 377 (0.3) [M+], 361 (15), 232 (30), 203 (100), 152 (43).
( Z )-Ethyl 3-Hydroxy-2-(iodomethylene)-3- p -tolyl-butanoate (Entry 15).
IR: 3490, 2980, 1722, 1298, 1184, 1028, 820 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.29 (2 H, d, J = 8.4 Hz), 7.13 (2 H, d, J = 8.4 Hz), 7.04 (1 H, s), 4.16 (2 H, m), 3.74 (1 H, s), 2.33 (3 H, s), 1.69 (3 H, s), 1.18 (3 H, t, J = 7.2 Hz). 13C NMR (125 MHz, CDCl3): δ = 167.95, 150.39, 141.96, 137.38, 129.19, 125.26, 83.48, 77.96, 61.76, 28.91, 21.21, 14.04. MS: m/e (relative intensity) = 360 (0.005) [M+], 344 (10), 216 (100), 188 (36), 120 (10).
( Z )-Ethyl 3-Hydroxy-2-(iodomethylene)-3- o -tolyl-butanoate (Entry 16).
IR: 3498, 2980, 1722, 1295, 1182, 1027, 483 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.52 (1 H, m), 7.17 (3 H, m), 6.82 (1 H, s), 4.15 (2 H, m), 3.39 (1 H, br s), 2.39 (3 H, s), 1.82 (3 H, s), 1.14 (3 H, t, J = 7.2 Hz). 13C NMR (125 MHz, CDCl3): δ = 167.78, 150.96, 141.63, 136.15, 132.49, 128.82, 126.05, 125.96, 81.78, 78.22, 61.52, 28.69, 21.95, 14.12. MS: m/e (relative intensity) = 359 (0.0015) [M+], 216 (100), 144 (33), 120 (13). ( Z )-Ethyl 3-Hydroxy-2-(iodomethylene)-3,4,4-trimethylpentanoate (Entry 18).
IR: 3520, 2958, 1723, 1289, 1180, 503 cm-1. 1H NMR (500 MHz, CDCl3): δ = 6.79 (1 H, s) 4.30 (2 H, m), 2.44 (1 H, br s) 1.45 (1 H, s), 1.37 (3 H, t, J = 7.0 Hz), 0.98 (9 H, s). 13C NMR (125 MHz, CDCl3): δ = 169.14, 152.41, 81.92, 81.08, 61.68, 38.98, 25.81, 24.71, 14.10. MS: m/e (relative intensity) = 326 (0.15) [M+], 309 (100), 272 (30), 226 (13), 146 (10).
( Z )-Ethyl 3-Hydroxy-2-(iodomethylene)-3-phenyl-pentanoate (Entry 19).
IR: 3489, 2978, 1721, 1299, 1185, 701 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.33 (5 H, m) 7.00 (1 H, s), 4.14 (2 H, q, J = 7.2 Hz), 3.58 (1 H, s), 2.06 (2 H, m), 1.14 (3 H, t, J = 5.8 Hz), 0.82 (3 H, t, J = 7.2 Hz). 13C NMR (75 MHz, CDCl3): δ = 168.20, 150.37, 142.72, 128.89, 127.62, 126.14, 83.15, 80.31, 61.77, 32.70, 14.04, 7.95. MS: m/e (relative intensity) = 360 (0.01) [M+], 331 (30), 216 (100), 108 (8).